Poxel SA (LTS:0RA2)
€ 0.1424 0 (0%) Market Cap: 7.53 Mil Enterprise Value: 52.36 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 8/100

Half Year 2021 Poxel SA Earnings Call(English) Transcript

Sep 23, 2021 / 05:00PM GMT
Release Date Price: €6.29 (-4.66%)
Operator

Hello, everyone. Welcome to Poxel's Half Year 2021 Results Presentation. (Operator Instructions) Thomas, I give you the floor.

Thomas Kuhn
Poxel S.A. - Co-Founder, CEO & Director

Thank you very much, and thank you for joining us today. I'm Thomas Kuhn, I'm the CEO of the company. After my introductory comments, I will hand the call to Anne Renevot, our CFO, to review the first half 2021 financial results. And then David Moller, Chief Scientific Officer, will provide an update on our clinical pipeline.

Before we begin, this is our forward-looking statements. Just to remind that forward-looking statements are subject to inherent risks and uncertainties beyond the company's control that could cause the company's actual results or performance to be materially different from the expected results or performance expressed or implied by such forward-looking statements. Further information can be found in our most recent regulatory filings.

So as some of you know, Poxel's mission and vision remain to discover, develop and commercialize innovative

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot